SPPI logo

Spectrum Pharmaceuticals (SPPI) Cash From Financing

Annual CFF

$75.59 M
+$22.28 M+41.80%

December 31, 2022

Summary

Performance

1-Year Change

+41.8%

3-Year Change

+685.2%

5-Year Change

-30.47%

15-Year Change

-30.47%

SPPI Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$108.72 M
SPPI annual cash flow from financing activities is currently -30.47% below its historical high of $108.72 million

3-Year Low

$53.31 M
SPPI annual cash flow from financing activities is currently +41.80% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
SPPI previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
SPPI next annual earnings announcement has not yet been scheduled

OtherSPPIcash flowmetrics:

Annual CFI

-$26.72 M
SPPI annual cash flow from investing activities is -$26.72 million

Annual CFO

-$96.99 M
SPPI annual cash flow from operations is -$96.99 million

Annual FCF

-$97.26 M
SPPI annual free cash flow is -$97.26 million

Annual CAPEX

$273.00 K
SPPI annual capital expenditures is $273.00 thousand

Quarterly CFF

$2.11 M
+$2.19 M+2808.97%

March 31, 2023

Summary

Performance

3-Month Change

+2808.97%

1-Year Change

-89.44%

3-Year Change

+100%

5-Year Change

+110%

SPPI Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$115.81 M
SPPI quarterly cash flow from financing activities is currently -98.18% below its historical high of $115.81 million

3-Year Low

-$78.00 K

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
SPPI previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
SPPI next earnings announcement has not yet been scheduled

OtherSPPIcash flowmetrics:

Quarterly CFI

$31.33 M
SPPI quarterly cash flow from investing activities is $31.33 million

Quarterly CFO

-$21.44 M
SPPI quarterly cash flow from operations is -$21.44 million

Quarterly FCF

-$21.55 M
SPPI quarterly free cash flow is -$21.55 million

Quarterly CAPEX

$108.00 K
SPPI quarterly capital expenditures is $108.00 thousand

TTM CFF

$57.70 M
-$17.89 M-23.66%

March 31, 2023

Summary

Performance

3-Month Change

-23.66%

1-Year Change

+11.07%

3-Year Change

+556.03%

5-Year Change

+499.4%

SPPI TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$137.03 M
SPPI TTM cash flow from financing activities is currently -57.89% below its historical high of $137.03 million

3-Year Low

$25.42 M
SPPI TTM cash flow from financing activities is currently +127.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
SPPI previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
SPPI next earnings announcement has not yet been scheduled

OtherSPPIcash flowmetrics:

TTM CFI

$4.18 M
SPPI TTM cash flow from investing activities is $4.18 million

TTM CFO

-$88.13 M
SPPI TTM cash flow from operations is -$88.13 million

TTM FCF

-$88.47 M
SPPI TTM free cash flow is -$88.47 million

TTM CAPEX

$342.00 K
SPPI TTM capital expenditures is $342.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

SPPI Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+41.8%-89.4%+11.1%
3 y3 years+685.2%+100.0%+556.0%
5 y5 years-30.5%+110.0%+499.4%

SPPI Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-29.5%-95.8%-103.7%-24.0%-56.0%
5 y5-year-11.3%-87.3%-97.4%-103.7%-57.2%-88.1%
alltimeall time-30.5%-111.2%-98.2%-1206.0%-57.9%-195.1%

Spectrum Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Mar 2023
-
$2.11 M(-2809.0%)
$57.70 M(-23.7%)
Dec 2022
$75.59 M(+41.8%)
-$78.00 K(-100.2%)
$75.59 M(-0.4%)
Sep 2022
-
$50.47 M(+869.7%)
$75.88 M(+198.5%)
Jun 2022
-
$5.20 M(-74.0%)
$25.42 M(-51.1%)
Mar 2022
-
$20.00 M(+9423.8%)
$51.95 M(-2.5%)
Dec 2021
$53.31 M(-37.5%)
$210.00 K(>+9900.0%)
$53.31 M(-0.2%)
Sep 2021
-
$2000.00(-100.0%)
$53.40 M(-60.4%)
Jun 2021
-
$31.74 M(+48.6%)
$134.97 M(+26.6%)
Mar 2021
-
$21.36 M(+7042.8%)
$106.59 M(+25.1%)
Dec 2020
$85.23 M(+785.3%)
$299.00 K(-99.6%)
$85.23 M(-0.8%)
Sep 2020
-
$81.58 M(+2333.0%)
$85.94 M(+1151.3%)
Jun 2020
-
$3.35 M(>+9900.0%)
$6.87 M(-21.9%)
Mar 2020
-
$0.00(-100.0%)
$8.80 M(-8.6%)
Dec 2019
$9.63 M(-213.8%)
$1.01 M(-59.6%)
$9.63 M(-34.2%)
Sep 2019
-
$2.50 M(-52.6%)
$14.62 M(-3.5%)
Jun 2019
-
$5.28 M(+535.5%)
$15.16 M(+12.3%)
Mar 2019
-
$831.00 K(-86.2%)
$13.49 M(-259.6%)
Dec 2018
-$8.46 M(-107.8%)
$6.01 M(+97.7%)
-$8.46 M(-61.0%)
Sep 2018
-
$3.04 M(-16.0%)
-$21.69 M(-123.8%)
Jun 2018
-
$3.62 M(-117.1%)
$91.09 M(+3.1%)
Mar 2018
-
-$21.12 M(+192.3%)
$88.39 M(-18.7%)
Dec 2017
$108.72 M(+82.3%)
-$7.23 M(-106.2%)
$108.72 M(+1.9%)
Sep 2017
-
$115.81 M(>+9900.0%)
$106.68 M(+446.8%)
Jun 2017
-
$920.00 K(-216.8%)
$19.51 M(-67.0%)
Mar 2017
-
-$788.00 K(-91.5%)
$59.20 M(-0.7%)
Dec 2016
$59.64 M(+3954.7%)
-$9.26 M(-132.3%)
$59.64 M(-13.8%)
Sep 2016
-
$28.64 M(-29.5%)
$69.19 M(+69.1%)
Jun 2016
-
$40.61 M(<-9900.0%)
$40.92 M(+4041.9%)
Mar 2016
-
-$341.00 K(-220.5%)
$988.00 K(-32.8%)
Dec 2015
$1.47 M(+81.2%)
$283.00 K(-23.9%)
$1.47 M(+67.9%)
Sep 2015
-
$372.00 K(-44.8%)
$876.00 K(+65.0%)
Jun 2015
-
$674.00 K(+374.6%)
$531.00 K(-285.0%)
Mar 2015
-
$142.00 K(-145.5%)
-$287.00 K(-135.3%)
Dec 2014
$812.00 K(-97.7%)
-$312.00 K(-1255.6%)
$812.00 K(-99.0%)
Sep 2014
-
$27.00 K(-118.8%)
$78.48 M(+42.5%)
Jun 2014
-
-$144.00 K(-111.6%)
$55.08 M(+46.6%)
Mar 2014
-
$1.24 M(-98.4%)
$37.58 M(+6.6%)
Dec 2013
$35.26 M(-42.2%)
$77.36 M(-431.0%)
$35.26 M(-164.3%)
Sep 2013
-
-$23.37 M(+32.4%)
-$54.86 M(-244.9%)
Jun 2013
-
-$17.64 M(+1527.7%)
$37.87 M(-36.4%)
Mar 2013
-
-$1.08 M(-91.5%)
$59.53 M(-2.4%)
Dec 2012
$61.02 M(+158.5%)
-$12.77 M(-118.4%)
$61.02 M(-16.0%)
Sep 2012
-
$69.37 M(+1627.7%)
$72.64 M(+182.9%)
Jun 2012
-
$4.01 M(+881.7%)
$25.68 M(+12.9%)
Mar 2012
-
$409.00 K(-135.4%)
$22.75 M(-3.7%)
Dec 2011
$23.61 M(+556.0%)
-$1.16 M(-105.2%)
$23.61 M(-12.5%)
Sep 2011
-
$22.41 M(+1971.3%)
$27.00 M(+442.8%)
Jun 2011
-
$1.08 M(-15.1%)
$4.97 M(+2.5%)
Mar 2011
-
$1.27 M(-42.9%)
$4.85 M(+34.9%)
Dec 2010
$3.60 M(-96.2%)
$2.23 M(+478.2%)
$3.60 M(+102.6%)
Sep 2010
-
$386.00 K(-59.9%)
$1.78 M(-97.5%)
Jun 2010
-
$962.00 K(+4963.2%)
$71.19 M(-25.8%)
Mar 2010
-
$19.00 K(-95.4%)
$95.96 M(+0.0%)
DateAnnualQuarterlyTTM
Dec 2009
$95.94 M(+131.2%)
$409.00 K(-99.4%)
$95.94 M(-30.0%)
Sep 2009
-
$69.80 M(+171.2%)
$137.03 M(+103.8%)
Jun 2009
-
$25.73 M(>+9900.0%)
$67.23 M(+62.0%)
Mar 2009
-
$0.00(-100.0%)
$41.50 M(0.0%)
Dec 2008
$41.50 M(+35.4%)
$41.50 M(>+9900.0%)
$41.50 M(<-9900.0%)
Sep 2008
-
$0.00(0.0%)
-$32.00 K(-245.5%)
Jun 2008
-
$0.00(0.0%)
$22.00 K(-99.9%)
Mar 2008
-
$0.00(-100.0%)
$30.32 M(-1.1%)
Dec 2007
$30.65 M(+6725.8%)
-$32.00 K(-159.3%)
$30.65 M(-1.5%)
Sep 2007
-
$54.00 K(-99.8%)
$31.11 M(+0.2%)
Jun 2007
-
$30.30 M(+9080.6%)
$31.06 M(+3886.9%)
Mar 2007
-
$330.00 K(-23.6%)
$779.00 K(+73.5%)
Dec 2006
$449.00 K(-98.9%)
$432.00 K(>+9900.0%)
$449.00 K(+3641.7%)
Sep 2006
-
$0.00(-100.0%)
$12.00 K(-100.0%)
Jun 2006
-
$17.00 K(>+9900.0%)
$38.96 M(+0.0%)
Mar 2006
-
$0.00(-100.0%)
$38.95 M(-4.4%)
Dec 2005
$40.75 M(+63.7%)
-$5000.00(-100.0%)
$40.75 M(+0.3%)
Sep 2005
-
$38.95 M(>+9900.0%)
$40.61 M(+2609.1%)
Jun 2005
-
$3000.00(-99.8%)
$1.50 M(-94.1%)
Mar 2005
-
$1.80 M(-1344.1%)
$25.42 M(+2.1%)
Dec 2004
$24.89 M(-19.7%)
-$145.00 K(-11.0%)
$24.89 M(-10.0%)
Sep 2004
-
-$163.00 K(-100.7%)
$27.66 M(-45.2%)
Jun 2004
-
$23.92 M(+1771.7%)
$50.47 M(+58.2%)
Mar 2004
-
$1.28 M(-51.3%)
$31.90 M(+2.9%)
Dec 2003
$31.00 M(+244.9%)
$2.63 M(-88.4%)
$31.00 M(+4.7%)
Sep 2003
-
$22.64 M(+322.9%)
$29.62 M(+280.9%)
Jun 2003
-
$5.35 M(+1313.1%)
$7.78 M(+96.9%)
Mar 2003
-
$378.90 K(-69.5%)
$3.95 M(-56.1%)
Dec 2002
$8.99 M(-58.9%)
$1.24 M(+55.1%)
$8.99 M(-36.4%)
Sep 2002
-
$800.90 K(-47.6%)
$14.14 M(+49.2%)
Jun 2002
-
$1.53 M(-71.8%)
$9.48 M(-50.3%)
Mar 2002
-
$5.42 M(-15.2%)
$19.08 M(-12.7%)
Dec 2001
$21.86 M(-51.9%)
$6.39 M(-265.5%)
$21.86 M(+16.0%)
Sep 2001
-
-$3.86 M(-134.7%)
$18.84 M(-51.9%)
Jun 2001
-
$11.13 M(+35.8%)
$39.20 M(-11.4%)
Mar 2001
-
$8.20 M(+143.1%)
$44.23 M(-2.7%)
Dec 2000
$45.45 M(+67.4%)
$3.37 M(-79.5%)
$45.45 M(-13.1%)
Sep 2000
-
$16.49 M(+2.0%)
$52.33 M(+17.8%)
Jun 2000
-
$16.17 M(+71.7%)
$44.44 M(+38.6%)
Mar 2000
-
$9.42 M(-8.2%)
$32.07 M(+18.1%)
Dec 1999
$27.15 M(+412.3%)
$10.25 M(+19.2%)
$27.15 M(+35.1%)
Sep 1999
-
$8.60 M(+126.3%)
$20.10 M(+53.4%)
Jun 1999
-
$3.80 M(-15.6%)
$13.10 M(+35.1%)
Mar 1999
-
$4.50 M(+40.6%)
$9.70 M(+83.0%)
Dec 1998
$5.30 M(+2550.0%)
$3.20 M(+100.0%)
$5.30 M(+253.3%)
Sep 1998
-
$1.60 M(+300.0%)
$1.50 M(+114.3%)
Jun 1998
-
$400.00 K(+300.0%)
$700.00 K(+133.3%)
Mar 1998
-
$100.00 K(-116.7%)
$300.00 K(+50.0%)
Dec 1997
$200.00 K(-98.9%)
-$600.00 K(-175.0%)
$200.00 K(-75.0%)
Sep 1997
-
$800.00 K(>+9900.0%)
$800.00 K(>+9900.0%)
Jun 1997
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1997
-
$0.00
$0.00
Dec 1996
$18.80 M
-
-

FAQ

  • What is Spectrum Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals annual CFF year-on-year change?
  • What is Spectrum Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals quarterly CFF year-on-year change?
  • What is Spectrum Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals TTM CFF year-on-year change?

What is Spectrum Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of SPPI is $75.59 M

What is the all time high annual CFF for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high annual cash flow from financing activities is $108.72 M

What is Spectrum Pharmaceuticals annual CFF year-on-year change?

Over the past year, SPPI annual cash flow from financing activities has changed by +$22.28 M (+41.80%)

What is Spectrum Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of SPPI is $2.11 M

What is the all time high quarterly CFF for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high quarterly cash flow from financing activities is $115.81 M

What is Spectrum Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, SPPI quarterly cash flow from financing activities has changed by -$17.89 M (-89.44%)

What is Spectrum Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of SPPI is $57.70 M

What is the all time high TTM CFF for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high TTM cash flow from financing activities is $137.03 M

What is Spectrum Pharmaceuticals TTM CFF year-on-year change?

Over the past year, SPPI TTM cash flow from financing activities has changed by +$5.75 M (+11.07%)